Simplex Trading’s Centessa Pharmaceuticals CNTA Stock Holding History

Simplex Trading’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.55M	Buy	+39,100	New	+$1M	﹤0.01%	2051
2025 Q4	–	Sell	-102,400	Closed	-$2.48M	–	8740
2025 Q3	$2.48M	Buy	102,400 +99,500	+3,431%	+$1.77M	﹤0.01%	2109
2025 Q2	$38K	Buy	2,900 +2,800	+2,800%	+$35.5K	﹤0.01%	6182
2025 Q1	$1K	Buy	+100	New	+$1.64K	﹤0.01%	8172
2024 Q4	–	Sell	-100	Closed	-$1K	–	8638
2024 Q3	$1K	Buy	+100	New	+$1.23K	﹤0.01%	8159
2024 Q2	–	Sell	-1,800	Closed	-$20K	–	8910
2024 Q1	$20K	Buy	+1,800	New	+$17K	﹤0.01%	7077

Other funds holding CNTA

MVM

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

IVLAV

Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Simplex Trading's CNTA Position: Q4 2025 in Review

Simplex Trading sold out of Centessa Pharmaceuticals (CNTA) in Q4 2025, closing a stake of 2,622 shares — an estimated $63K sold.

Simplex Trading first reported a position in CNTA in Q3 2022 and held it in 5 quarters. The position peaked at $63K in Q3 2025. 146 funds tracked by Wall St. Rank hold CNTA as of Q4 2025.

Simplex Trading reported no remaining Centessa Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Simplex Trading sold 2,622 Centessa Pharmaceuticals shares in Q4 2025, an estimated $63K.
Simplex Trading first reported a position in Centessa Pharmaceuticals in Q3 2022 and held it in 5 quarters.
Simplex Trading's Centessa Pharmaceuticals position peaked at $63K in Q3 2025.
146 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.